查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1632592

全球脈衝電場消融市場：市場規模、佔有率和趨勢分析（按組件、適應症、最終用途、地區和細分市場，2025-2030 年）

Pulsed Field Ablation Market Size, Share & Trends Analysis Report By Components (Catheters, Generators), By Indication (Atrial Fibrillation, Non Atrial Fibrillation), By End Use (Inpatient, Outpatient), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

脈衝電場消融市場規模與趨勢：

2024 年全球脈衝電場消融市場規模估計為 9.131 億美元，預計 2025 年至 2030 年的複合年成長率為 33.1%。

背後的原因是，它有望成為傳統熱消融方法更安全、更有效的替代方案。隨著世界各地心房顫動（AF）盛行率的不斷上升，對併發症更少、療效更好的創新治療方案的需求也日益成長。脈衝電場消融(PFA) 的非熱機制顯著降低了損傷周圍組織的風險，這是射頻和冷凍消融等傳統消融技術的主要限制。這一獨特的優勢引起了醫療保健提供者和患者越來越多的興趣，加速了其在臨床實踐中的應用。

心律不整，特別是心房顫動（AF），越來越普遍，影響著全世界數百萬人。心房顫動的特徵是心率不規則且通常很快，是最常見的持續性心律不整類型，會顯著增加中風、心臟衰竭和其他嚴重心血管併發症的風險。隨著世界人口老化以及高血壓、肥胖等生活型態相關風險因子的發生率上升，心房顫動病例數也隨之增加。根據強生服務公司 2024 年 2 月發表的一篇報導，全球有超過 3,750 萬人患有這種疾病，凸顯了其影響的廣泛性。發生心房顫動的風險特別高，統計數據顯示，大約四分之一的 40 歲以上的成年人在一生中的某個時刻會經歷這種心律不整。盛行率的不斷上升凸顯了有效管理和預防策略的迫切需求。

日益加重的負擔對有效、微創治療方法產生了巨大的需求。傳統治療方法，如抗心律不整藥物和導管消融，有其局限性，需要更安全、更有效的方法。因此，心律不整盛行率的不斷上升是脈衝電場消融(PFA) 等先進治療技術市場成長的主要驅動力，與傳統方法相比，該技術具有更高的安全性和有效性。根據2024年2月《柳葉刀區域健康-歐洲》雜誌發表的一篇論文，心房顫動（AF）影響著1.5-2％的歐洲成年人，預計到2060年將增加到65歲及以上人群的9.5％。心房顫動是導致中風、失智症、心臟衰竭和過早死亡的重要危險因素，對老化社會和醫療保健系統構成挑戰。

技術創新提高了消融手術的準確性、安全性和有效性，是 PFA 產業成長的主要驅動力。領先的醫療設備公司正在大力投資開發下一代 PFA 系統，重點是能量輸送、導管設計和程序效率的改進。導管靈活性的創新以及即時成像和映射技術的整合使得消融更加有針對性和可控，從而降低了併發症的風險並改善了患者的治療效果。 2024 年 10 月，雅培宣佈在電生理學脈衝電場消融技術方面取得重大進展。該公司已完成 VOLT-AF IDE 試驗的招募，評估其 Volt PFA 系統，並已啟動 FOCALFLEX 試驗，測試其 TactiFlex Duo 消融導管用於治療陣發性心房顫動。這些舉措代表著雅培 PFA 導管的重大進步。

監管部門的核准對 PFA 行業來說非常重要，因為它將檢驗這些新設備的安全性和有效性，並為更廣泛的臨床應用鋪平道路。近年來，多種 PFA 系統已在歐洲獲得 CE 標誌，允許其在整個歐洲銷售和使用。這些核准通常基於積極的臨床試驗結果，證明了 PFA 優於傳統方法，特別是在縮短手術時間和減少併發症方面。 2024年10月，Medtronic獲得FDA核准，推出搭載Sphere-9導管的Affera測繪與消融系統，用於治療持續性心房顫動與心房撲動。這使得Medtronic成為第一家擁有兩項經 FDA核准的治療心房顫動脈衝電場消融(PFA) 技術的公司。 Sphere-9 導管憑藉其 9 毫米網格尖端提供靈活的治療選擇，並與 Pulse Select PFA 系統相輔相成，為肺靜脈隔離提供單次注射解決方案。

目錄

第1章 分析方法及範圍

第 2 章執行摘要

第3章脈衝電場消融市場：促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 脈衝電場消融市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析

第 4 章脈衝電場消融市場：按組件進行估計和趨勢分析

  • 細分儀表板
  • 脈衝電場消融市場：按組件進行的變化分析
  • 脈衝電場消融市場展望（按組件）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 導管
  • 發電機

第 5 章脈衝電場消融市場：按適應症進行估計和趨勢分析

  • 細分儀表板
  • 脈衝電場消融市場：依適應症進行變化分析
  • 脈衝電場消融市場前景（按適應症）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 心房顫動
  • 非心房顫動

第6章脈衝電場消融市場：依最終用途的估計與趨勢分析

  • 細分儀表板
  • 脈衝電場消融市場：依最終用途進行變化分析
  • 脈衝電場消融市場前景（依最終用途）
  • 市場規模預測及趨勢分析（2018-2030年）
  • 住院設施
  • 門診設施

第 7 章脈衝電場消融市場：按地區估計和趨勢分析

  • 區域控制面板
  • 市場規模預測及趨勢分析（2018-2030年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第8章 競爭格局

  • 市場參與企業分類
  • 主要企業簡介
    • Boston Scientific Corporation
    • Abbott
    • Medtronic
    • Biosense Webster, Inc. (Johnson &Johnson Services, Inc)
    • Pulse Biosciences, Inc
    • Kardium
    • Jia Jing Electronic Co., Ltd.
    • Adagio Medical Inc
    • CardioFocus
    • Acutus Medical, Inc
Product Code: GVR-4-68040-411-3

Pulsed Field Ablation Market Size & Trends:

The global pulsed field ablation market size was estimated at USD 913.1 million in 2024 and is projected to grow at a CAGR of 33.1% from 2025 to 2030. This is driven by its promise as a safer and more effective alternative to traditional thermal ablation methods. As the global prevalence of atrial fibrillation (AF) rises, there is an increasing demand for innovative treatment options that offer fewer complications and improved outcomes. pulsed field ablation (PFA) non-thermal mechanism significantly reduces the risk of damaging surrounding tissues, a major limitation of conventional ablation techniques like radiofrequency and cryoablation. This unique advantage has led to growing interest from healthcare providers and patients, accelerating its adoption in clinical settings.

Cardiac arrhythmias, particularly atrial fibrillation (AF), are increasingly prevalent, affecting millions worldwide. AF, characterized by an irregular and often rapid heart rate, is the most common type of sustained arrhythmia, significantly raising the risk of stroke, heart failure, and other serious cardiovascular complications. As global populations age and the incidence of lifestyle-related risk factors, such as hypertension and obesity, rises, the number of AF cases continues to grow. According to the Johnson & Johnson Services, Inc. article published in February 2024, more than 37.5 million people globally live with this condition, emphasizing its widespread impact. The risk of developing AFib is notably high; statistics reveal that about one in four adults over the age of 40 experience this arrhythmia at some point in their lives. This growing prevalence highlights the urgent need for effective management and prevention strategies.

This escalating burden has created a substantial demand for effective, minimally invasive treatment options. Traditional therapies such as antiarrhythmic drugs and catheter-based ablation have limitations, leading to an unmet need for safer, more efficient approaches. The increasing prevalence of arrhythmias is thus a key driver of market growth for advanced treatment technologies like pulsed field ablation (PFA), which offer improved safety profiles and efficacy compared to conventional methods. In February 2024, an article in The Lancet Regional Health - Europe highlighted that atrial fibrillation (AF) affects 1.5-2% of European adults, expected to rise to 9.5% in those over 65 by 2060. AF is a significant risk factor for stroke, dementia, heart failure, and premature mortality, posing challenges for the aging population and healthcare systems.

Technological advancements are a key driver of the PFA industry's growth, as ongoing innovations enhance ablation procedures precision, safety, and efficacy. Leading medical device companies are investing heavily in the development of next-generation PFA systems, focusing on improving energy delivery, catheter design, and procedural efficiency. Innovations in catheter flexibility and the integration of real-time imaging and mapping technologies allow for more targeted and controlled ablation, reducing the risk of complications and improving patient outcomes. In October 2024, Abbott announced important advancements in its pulsed field ablation technologies for electrophysiology. The company finished enrolling participants in the VOLT-AF IDE Study aimed at evaluating the Volt PFA System and initiated the FOCALFLEX trial to test the TactiFlex Duo Ablation Catheter for treating paroxysmal atrial fibrillation. These initiatives mark significant progress for Abbott's PFA catheters.

Regulatory approvals are critical in influencing the PFA industry, as they validate the safety and efficacy of these novel devices, paving the way for broader clinical adoption. In recent years, several PFA systems have received CE marking in Europe, allowing them to be marketed and used across the continent. These approvals are often based on positive clinical trial results that demonstrate the benefits of PFA over traditional methods, particularly in terms of reduced procedure times and fewer complications. In October 2024, Medtronic received FDA approval for the Affera Mapping and Ablation System with Sphere-9 Catheter, designed for persistent atrial fibrillation and atrial flutter treatment. This makes Medtronic the first company with two FDA-approved pulsed-field ablation (PFA) technologies for AFib. The Sphere-9 catheter offers flexible treatment options with its 9mm lattice tip, complementing the PulseSelect PFA System, which provides a single-shot solution for pulmonary vein isolation.

Global Pulsed Field Ablation Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global pulsed field ablation market report based on the components, indication, end use, and region.

  • Components Outlook (Revenue, USD Million, 2018 - 2030)
  • Catheters
  • Generators
  • Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Atrial Fibrillation
  • Non-atrial Fibrillation
  • End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Inpatient Facilities
  • Outpatient Facilities
  • Regional Outlook (Revenue, USD Million; 2018 - 2030)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Components
    • 1.2.2. Indication
    • 1.2.3. End use
    • 1.2.4. Regional Scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Components outlook
    • 2.2.2. Indication outlook
    • 2.2.3. End use outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Pulsed Field Ablation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of cardiac arrhythmias
      • 3.2.1.2. Technological advancements in PFA devices
      • 3.2.1.3. Minimally invasive nature of PFA
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High costs of PFA devices and procedures
      • 3.2.2.2. Lack of long-term data on effectiveness and safety
  • 3.3. Pulsed Field Ablation Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Pulsed Field Ablation Market: Components Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Pulsed Field Ablation Market: Components Movement Analysis
  • 4.3. Pulsed Field Ablation Market by Components Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 4.5. Catheters
    • 4.5.1. Catheters Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Generators
    • 4.6.1. Generators Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pulsed Field Ablation Market: Indication Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Pulsed Field Ablation Market: Indication Movement Analysis
  • 5.3. Pulsed Field Ablation Market by Indication Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 5.5. Atrial Fibrillation
    • 5.5.1. Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Non-Atrial Fibrillation
    • 5.6.1. Non-Atrial Fibrillation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pulsed Field Ablation Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Pulsed Field Ablation Market: End Use Movement Analysis
  • 6.3. Pulsed Field Ablation Market by End Use Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. Inpatient Facilities
    • 6.5.1. Inpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Outpatient Facilities
    • 6.6.1. Outpatient Facilities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pulsed Field Ablation Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Market Participant Categorization
  • 8.2. Key Company Profiles
    • 8.2.1. Boston Scientific Corporation
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Abbott
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Medtronic
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. Biosense Webster, Inc. (Johnson & Johnson Services, Inc)
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Pulse Biosciences, Inc
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Kardium
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Jia Jing Electronic Co., Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Adagio Medical Inc
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. CardioFocus
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Acutus Medical, Inc
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 4 Global pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 5 Global pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 6 North America pulsed field ablation market, by region, 2018 - 2030 (USD Million)
  • Table 7 North America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 8 North America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 9 North America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 10 U.S pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 11 U.S pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 12 U.S pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 13 Canada pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 14 Canada pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 15 Canada pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 16 Mexico pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 17 Mexico pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 18 Mexico pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Europe pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 21 Europe pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 22 Europe pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 23 UK pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 24 UK pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 25 UK pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 26 Germany pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 27 Germany pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 28 Germany pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 29 France pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 30 France pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 31 France pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 32 Italy pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 33 Italy pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 34 Italy pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 35 Spain pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 36 Spain pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 37 Spain pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Denmark pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 39 Denmark pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 40 Denmark pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 41 Norway pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 42 Norway pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 43 Norway pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Sweden pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 45 Sweden pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 46 Sweden pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Japan pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 52 Japan pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 53 Japan pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 54 China pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 55 China pulsed field ablation market, by indication 2018 - 2030 (USD Million)
  • Table 56 China pulsed field ablation market, by end use 2018 - 2030 (USD Million)
  • Table 57 India pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 58 India pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 59 India pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Australia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 61 Australia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 62 Australia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 63 South Korea pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 64 South Korea pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 65 South Korea pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 66 Thailand pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 67 Thailand pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 68 Thailand pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Latin America pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 71 Latin America pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 72 Latin America pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 73 Brazil pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 74 Brazil pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 75 Brazil pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 76 Argentina pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 77 Argentina pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 78 Argentina pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa pulsed field ablation market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 83 South Africa pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 84 South Africa pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 85 South Africa pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 89 UAE pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 90 UAE pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 91 UAE pulsed field ablation market, by end use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait pulsed field ablation market, by components, 2018 - 2030 (USD Million)
  • Table 93 Kuwait pulsed field ablation market, by indication, 2018 - 2030 (USD Million)
  • Table 94 Kuwait pulsed field ablation market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Market research approaches
  • Fig. 4 Market formulation & validation
  • Fig. 5 Pulsed field ablation market segmentation
  • Fig. 6 Market driver analysis (current & future impact)
  • Fig. 7 Market restraint analysis (current & future impact)
  • Fig. 8 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 9 Porter's five forces analysis
  • Fig. 10 Pulsed field ablation market, components outlook key takeaways (USD Million)
  • Fig. 11 Pulsed field ablation market: components movement analysis (USD Million), 2024 & 2030
  • Fig. 12 Catheters market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 13 Generators market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Pulsed field ablation market, indication outlook key takeaways (USD Million)
  • Fig. 15 Pulsed field ablation market: indication movement analysis (USD Million), 2024 & 2030
  • Fig. 16 Atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 17 Non-atrial fibrillation market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Pulsed field ablation market, end use outlook key takeaways (USD Million)
  • Fig. 19 Pulsed field ablation market: end use movement analysis (USD Million), 2024 & 2030
  • Fig. 20 Inpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Outpatient facilities market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Pulsed field ablation market: regional key takeaways (USD Million)
  • Fig. 23 Pulsed field ablation market: regional outlook, 2024 & 2030, USD Million
  • Fig. 24 North America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 US pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Canada pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Mexico pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Europe pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 UK pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Germany pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 France pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Spain pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Italy pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Norway pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Asia Pacific pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 China pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Japan pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 India pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 South Korea pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Australia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Thailand pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Latin America pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Brazil pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Argentina pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Middle East and Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Africa pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Saudi Arabia pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 UAE pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Kuwait pulsed field ablation market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 List of key emerging company's/indication disruptors/innovators